Kinnate Biopharma Inc.
USD2.65
-0.01 (-0.38%)
CEO
Nima Farzan
IPO Date
2020-12-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.65
Prev. Close
$2.66
Day Low
$2.64
Day High
$2.67
52W Low
$1.04
52W High
$7.18
Market Cap
$0.12B
Volume
2.12M
| -2.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -28.0% | -24.4% | 0.00 | 20.88 | -8.6 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -9.0% | -8.8% | 0.00 | 54.79 | -48.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 68.2% | -15.4% | 0.00 | 39.82 | -141.8 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -100.3% | -94.5% | 0.00 | 17.30 | -221.6 |
| -0.5 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -16.2% | -14.8% | 0.02 | 11.96 | -1.1 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | -14.0% | -12.8% | 0.02 | 11.31 | -2.3 |
| 31 Dec 2022 | Q4 | 0.0% | 0.0% | -13.4% | -10.7% | 0.02 | 13.45 | -2.3 |
| 30 Sept 2022 | Q3 | 0.0% | 0.0% | -12.1% | -10.0% | 0.02 | 17.02 | -4.4 |
| 30 Jun 2022 | Q2 | 0.0% | 0.0% | -9.8% | -8.3% | 0.02 | 23.30 | -5.2 |
| 31 Mar 2022 | Q1 | 0.0% | 0.0% | -9.0% | -7.7% | 0.02 | 20.15 | -4.6 |
| 31 Dec 2021 | Q4 | 0.0% | 0.0% | -8.2% | -7.1% | 0.00 | 20.88 | -7.4 |
| 30 Sept 2021 | Q3 | 0.0% | 0.0% | -7.2% | -6.4% | 0.00 | 25.31 | -10.2 |